跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
G4-1
首页
药物
G4-1
G4-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FLUORINE-CONTAINING COMPOUND PRODUCTION METHOD
EP 4610245 A1
申请人: AGC INC
优先权: 2022
CN
EP
US
WO
4 件公开
TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS
EP 4805350 A1
申请人: TREELINE BIOSCIENCES INC
优先权: 2023
CN
EP
US
WO
4 件公开
Anti-Radical Agents
US 2008305055 A1
申请人: BASCHONG WERNER
优先权: 2004
EP
US
4 件公开
CN 101128193 B
申请人: CIBA SPEC CHEM CORP
优先权: 2005
CN
MONOCLONAL ANTIBODY AGAINST HLA-G MOLECULES AND USE THEREOF
EP 4501960 A4
申请人: TAIZHOU ENZE MEDICAL CT GROUP
优先权: 2022
CN
EP
US
3 件公开
HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME
US 2024010648 A1
申请人: SUMITOMO CHEMICAL CO
优先权: 2020
US
WO
3 件公开
US 12234247 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2019
CN
US
2 件公开
Aminotriazole compounds
US 6245916 B1
申请人: ADIR
优先权: 1999
US
3 件公开
1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
US 6683142 B2
申请人: CIBA SC HOLDING AG
优先权: 2001
US
3 件公开
Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
US 12053523 B2
申请人: UNIV NORTH CAROLINA STATE
优先权: 2017
CN
US
2 件公开
Substituted heterocycles as harmful arthropod controlling agents
US 11490622 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2017
CN
US
2 件公开
Heterocyclic compound and harmful arthropod control composition containing same
US 12144350 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2019
CN
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈